Media and Investor Contact: Jonae R. Barnes Vice President Investor Relations and Corporate Communications [removed]

First Page		Document Content
Date: 2014-05-30 08:46:05 Vaccine CD134 Biology Forward-looking statement Vaccination Business law Agenus		Media and Investor Contact: Jonae R. Barnes Vice President Investor Relations and Corporate Communications [removed] Add to Reading List Source URL: www.antigenics.com Download Document from Source Website File Size: 316,77 KB Share Document on Facebook

	PDF Document DocID: 17txF - View Document
	PDF Document DocID: 17mad - View Document
	Microsoft Word - Document1 DocID: 12z6m - View Document
	Review The origins, function, and regulation of T follicular helper cells Cindy S. Ma,1,2 Elissa K. Deenick,1,2 Marcel Batten,1,2 and Stuart G. Tangye1,2 DocID: 10Cx4 - View Document
	Considerations for Designing New Trials with Chimeric Antigen Receptors: June 15, 2010 RAC Safety Symposium DocID: GtpM - View Document